Literature DB >> 34251396

The Trial to Reduce Antimicrobial Use in Nursing Home Residents With Alzheimer Disease and Other Dementias (TRAIN-AD): A Cluster Randomized Clinical Trial.

Susan L Mitchell1,2, Erika M C D'Agata3, Laura C Hanson4, Andrea J Loizeau5, Daniel A Habtemariam1, Timothy Tsai1, Ruth A Anderson6, Michele L Shaffer7,8.   

Abstract

Importance: Antimicrobials are extensively prescribed to nursing home residents with advanced dementia, often without evidence of infection or consideration of the goals of care. Objective: To test the effectiveness of a multicomponent intervention to improve the management of suspected urinary tract infections (UTIs) and lower respiratory infections (LRIs) for nursing home residents with advanced dementia. Design, Setting, and Participants: A cluster randomized clinical trial of 28 Boston-area nursing homes (14 per arm) and 426 residents with advanced dementia (intervention arm, 199 residents; control arm, 227 residents) was conducted from August 1, 2017, to April 30, 2020. Interventions: The intervention content integrated best practices from infectious diseases and palliative care for management of suspected UTIs and LRIs in residents with advanced dementia. Components targeting nursing home practitioners (physicians, physician assistants, nurse practitioners, and nurses) included an in-person seminar, an online course, management algorithms (posters, pocket cards), communication tips (pocket cards), and feedback reports on prescribing of antimicrobials. The residents' health care proxies received a booklet about infections in advanced dementia. Nursing homes in the control arm continued routine care. Main Outcomes and Measures: The primary outcome was antimicrobial treatment courses for suspected UTIs or LRIs per person-year. Outcomes were measured for as many as 12 months. Secondary outcomes were antimicrobial courses for suspected UTIs and LRIs when minimal criteria for treatment were absent per person-year and burdensome procedures used to manage these episodes (bladder catherization, chest radiography, venous blood sampling, or hospital transfer) per person-year.
Results: The intervention arm had 199 residents (mean [SD] age, 87.7 [8.0] years; 163 [81.9%] women; 36 [18.1%] men), of which 163 (81.9%) were White and 27 (13.6%) were Black. The control arm had 227 residents (mean [SD] age, 85.3 [8.6] years; 190 [83.7%] women; 37 [16.3%] men), of which 200 (88.1%) were White and 22 (9.7%) were Black. There was a 33% (nonsignificant) reduction in antimicrobial treatment courses for suspected UTIs or LRIs per person-year in the intervention vs control arm (adjusted marginal rate difference, -0.27 [95% CI, -0.71 to 0.17]). This reduction was primarily attributable to reduced antimicrobial use for LRIs. The following secondary outcomes did not differ significantly between arms: antimicrobials initiated when minimal criteria were absent, bladder catheterizations, venous blood sampling, and hospital transfers. Chest radiography use was significantly lower in the intervention arm (adjusted marginal rate difference, -0.56 [95% CI, -1.10 to -0.03]). In-person or online training was completed by 88% of the targeted nursing home practitioners. Conclusions and Relevance: This cluster randomized clinical trial found that despite high adherence to the training, a multicomponent intervention promoting goal-directed care for suspected UTIs and LRIs did not significantly reduce antimicrobial use among nursing home residents with advanced dementia. Trial Registration: ClinicalTrials.gov Identifier: NCT03244917.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34251396      PMCID: PMC8276127          DOI: 10.1001/jamainternmed.2021.3098

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN: 2168-6106            Impact factor:   44.409


  4 in total

1.  BABEL (Better tArgeting, Better outcomes for frail ELderly patients) advance care planning: a comprehensive approach to advance care planning in nursing homes: a cluster randomised trial.

Authors:  Allan Garland; Heather Keller; Patrick Quail; Veronique Boscart; Michelle Heyer; Clare Ramsey; Vanessa Vucea; Nora Choi; Ikdip Bains; Seema King; Tatiana Oshchepkova; Tatiana Kalashnikova; Brittany Kroetsch; Jessica Steer; George Heckman
Journal:  Age Ageing       Date:  2022-03-01       Impact factor: 10.668

2.  Identification of Hub Genes and Immune Cell Infiltration Characteristics in Alzheimer's Disease.

Authors:  Ming Hu; Jianhua Wang
Journal:  J Healthc Eng       Date:  2021-12-20       Impact factor: 2.682

3.  Provider adherence to training components from the Trial to Reduce Antimicrobial use In Nursing home residents with Alzheimer's disease and other Dementias (TRAIN-AD) intervention.

Authors:  Meghan Hendricksen; Andrea J Loizeau; Daniel A Habtemariam; Ruth A Anderson; Laura C Hanson; Erika M C D'Agata; Susan L Mitchell
Journal:  Contemp Clin Trials Commun       Date:  2022-03-25

4.  Impact of interactive computerised decision support for hospital antibiotic use (COMPASS): an open-label, cluster-randomised trial in three Swiss hospitals.

Authors:  Gaud Catho; Julien Sauser; Valentina Coray; Serge Da Silva; Luigia Elzi; Stephan Harbarth; Laurent Kaiser; Christophe Marti; Rodolphe Meyer; Francesco Pagnamenta; Javier Portela; Virginie Prendki; Alice Ranzani; Nicolò Saverio Centemero; Jerome Stirnemann; Roberta Valotti; Nathalie Vernaz; Brigitte Waldispuehl Suter; Enos Bernasconi; Benedikt D Huttner
Journal:  Lancet Infect Dis       Date:  2022-07-20       Impact factor: 71.421

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.